tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SXTP Stock Latest News

60 Degrees receives FDA comments on Tafenoquine-Babesiosis trial protocol
The Fly60 Degrees receives FDA comments on Tafenoquine-Babesiosis trial protocol
1d ago
SXTP
60 Degrees price target raised to $1.30 from $1.20 at Ascendiant
PremiumThe Fly
60 Degrees price target raised to $1.30 from $1.20 at Ascendiant
25d ago
SXTP
60 Degrees Pharmaceuticals to sponsor pilot study of tafenoquine
PremiumThe Fly
60 Degrees Pharmaceuticals to sponsor pilot study of tafenoquine
1M ago
SXTP
60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
PremiumPress Releases
60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
1M ago
SXTP
60 Degrees announces FDA communication on trial protocol submission
PremiumThe Fly
60 Degrees announces FDA communication on trial protocol submission
2M ago
SXTP
60 Degrees Pharmaceuticals Embarks on Tafenoquine Research Partnership
PremiumCompany Announcements60 Degrees Pharmaceuticals Embarks on Tafenoquine Research Partnership
2M ago
8K
SXTP
60 Degrees Pharmaceuticals to sponsor pre-clinical studies of Tafenoquine use
PremiumThe Fly
60 Degrees Pharmaceuticals to sponsor pre-clinical studies of Tafenoquine use
2M ago
SXTP
60 Degrees Pharmaceuticals appoints Kristen Landon as CCO
PremiumThe Fly
60 Degrees Pharmaceuticals appoints Kristen Landon as CCO
3M ago
SXTP
TXMD
60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer
PremiumPress Releases
60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer
3M ago
SXTP
60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering
PremiumPress Releases
60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering
3M ago
SXTP
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
PremiumPress Releases
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
3M ago
SXTP
60 Degrees Pharmaceuticals prices 5.26M units at 38.5c in public offering
PremiumThe Fly
60 Degrees Pharmaceuticals prices 5.26M units at 38.5c in public offering
3M ago
SXTP
60 Degrees Pharmaceuticals files to sell 4.79M units
PremiumThe Fly60 Degrees Pharmaceuticals files to sell 4.79M units
3M ago
SXTP
60 Degrees plans babesiosis study with tafenoquine after FDA meeting
PremiumThe Fly
60 Degrees plans babesiosis study with tafenoquine after FDA meeting
3M ago
SXTP
60 Degrees Pharmaceuticals regains compliance with Nasdaq listing rules
PremiumThe Fly
60 Degrees Pharmaceuticals regains compliance with Nasdaq listing rules
4M ago
SXTP
H.C. Wainwright sees larger opportunity for 60 Degrees’ Arakoda in babesiosis
PremiumThe Fly
H.C. Wainwright sees larger opportunity for 60 Degrees’ Arakoda in babesiosis
4M ago
SXTP
60 Degrees reports IRB approval of Phase IIA study of tafenoquine
PremiumThe Fly
60 Degrees reports IRB approval of Phase IIA study of tafenoquine
4M ago
SXTP
60 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024
PremiumPress Releases
60 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024
4M ago
SXTP
60 Degrees Pharma Announces Type C Meeting with FDA to Discuss Development of Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease
PremiumPress Releases
60 Degrees Pharma Announces Type C Meeting with FDA to Discuss Development of Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease
6M ago
SXTP
60 Degrees Pharmaceuticals announces Type C Meeting with FDA for tafenoquine
PremiumThe Fly60 Degrees Pharmaceuticals announces Type C Meeting with FDA for tafenoquine
6M ago
SXTP
60 Degrees Pharmaceuticals initiated with a Neutral at H.C. Wainwright
PremiumThe Fly
60 Degrees Pharmaceuticals initiated with a Neutral at H.C. Wainwright
7M ago
SXTP
60 Degrees Pharmaceuticals to present data on tafenoquine antimalarial regimen
PremiumThe Fly
60 Degrees Pharmaceuticals to present data on tafenoquine antimalarial regimen
7M ago
SXTP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >